A-TAP - Arthritis Therapy Acceleration Programme
The Arthritis Therapy Acceleration Programme (A-TAP) is an exciting new £7M concept funded by the Kennedy Trust for Rheumatology Research. It brings together the Universities of Birmingham and Oxford and seven NHS partners and is supported by our access to over 7million patients. The initiative is aiming to support and develop novel treatments for arthritis based on the underlying causes of inflammatory disease.
This ambition is facilitated by our innovative new approach to translational inflammation research through our application of unique rigorous signal seeking experimental medicine studies leading to rapid adoption into clinical trials underpinned by novel trial design. The results will help us treat the cause of disease not just their symptoms and help develop a new taxonomy of disease that moves away from a traditional “organ-based, speciality-focussed” approach to a process-driven, pathway-focussed classification for inflammatory diseases.
Latest news from the Kennedy Institute
18 August 2020
Research shows how IL-22 interacts with KRAS mutant tumours to promote excessive growth in colorectal cancer
10 July 2020
Congratulations to Mariana Borsa for being awarded the Marie Skłodowska-Curie Actions – Individual Fellowship
8 July 2020
A building project to extend the Kennedy Institute of Rheumatology building with a new floor will create much needed space for the Institute to expand, particularly in the areas of data science and clinical trials.